Effects of some residual insecticides and their mixtures on stored grain pets

Imperial Users onl

Interaction of vortices in superconductors with kappa close to 2^(-1/2)

Using a perturbative approach to the infinitely degenerate Bogomolnyi vortex state for a superconductor with kappa = 2^(-1/2), T -> T_c, we calculate the interaction of vortices in a superconductor with kappa close to 2^(-1/2). We find, numerically and analytically, that depending on the material the interaction potential between the vortices varies with decreasing kappa from purely repulsive (as in a type-II superconductor) to purely attractive (as in a type-I superconductor) in two different ways: either vortices form a bound state and the distance between them changes gradually from infinity to zero, or this transition occurs in a discontinuous way as a result of a competition between minima at infinity and zero. We study the discontinuous transition between the vortex and Meissner states caused by the non-monotonous vortex interaction and calculate the corresponding magnetization jump.Comment: v1:original submit v2:changed formate of images (gave problems to some) v3:corrected fig v4v6 (was -v4v6) orthographic corrections (and U_lat/int) mismatch v4:more small orthographic corrections v5:converted to revtex4 and bibTex v6:Renamed images to submit to pr

Some biological responses of the diatom Nitzschia closterium (W. Smith) to copper and zinc

Some biological responses of the marine diatom Nitzschia closterium to copper and zinc were studied. The species was isolated from the Gulf of Suez and grown in liquid culture with enriched filtered seawater over a maximum period of 10 days. The results indicated that low concentrations of copper (1 and 5 μg.l-1) and zinc (10, 20 and 50 μg.l-1) stimulated the growth, photosynthetic pigments (chlorophyll-a,c and carotenoids), total soluble proteins as well as 02-evolution in photosynthesis and dark respiration (02uptake) of the diatom as compared with the control culture. Whereas, higher concentrations of 50, 100, 200 and 300 μg.l-1 copper and 100, 200, 300, 400 and 600 μg.l-1 zinc inhibited the above metabolic processes of the organism (taking into consideration that the culture treated with 10 μg.l-1 zinc produced the same O2-uptake as in the control culture). Statistically, there exists reverse correlation between the different concentrations of copper and zinc and the metabolic processes of Nitzschia closterium as proved with linear regression equations

Smoothness metrics for reaching performance after stroke:Part 1: which one to choose?

BACKGROUND: Smoothness is commonly used for measuring movement quality of the upper paretic limb during reaching tasks after stroke. Many different smoothness metrics have been used in stroke research, but a ‘valid’ metric has not been identified. A systematic review and subsequent rigorous analysis of smoothness metrics used in stroke research, in terms of their mathematical definitions and response to simulated perturbations, is needed to conclude whether they are valid for measuring smoothness. Our objective was to provide a recommendation for metrics that reflect smoothness after stroke based on: (1) a systematic review of smoothness metrics for reaching used in stroke research, (2) the mathematical description of the metrics, and (3) the response of metrics to simulated changes associated with smoothness deficits in the reaching profile. METHODS: The systematic review was performed by screening electronic databases using combined keyword groups Stroke, Reaching and Smoothness. Subsequently, each metric identified was assessed with mathematical criteria regarding smoothness: (a) being dimensionless, (b) being reproducible, (c) being based on rate of change of position, and (d) not being a linear transform of other smoothness metrics. The resulting metrics were tested for their response to simulated changes in reaching using models of velocity profiles with varying reaching distances and durations, harmonic disturbances, noise, and sub-movements. Two reaching tasks were simulated; reach-to-point and reach-to-grasp. The metrics that responded as expected in all simulation analyses were considered to be valid. RESULTS: The systematic review identified 32 different smoothness metrics, 17 of which were excluded based on mathematical criteria, and 13 more as they did not respond as expected in all simulation analyses. Eventually, we found that, for reach-to-point and reach-to-grasp movements, only Spectral Arc Length (SPARC) was found to be a valid metric. CONCLUSIONS: Based on this systematic review and simulation analyses, we recommend the use of SPARC as a valid smoothness metric in both reach-to-point and reach-to-grasp tasks of the upper limb after stroke. However, further research is needed to understand the time course of smoothness measured with SPARC for the upper limb early post stroke, preferably in longitudinal studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12984-021-00949-6

Effect of Additives on the Performance of the Fire-Clay Refractory Bricks

This work studied the effect of additive materials – ceramic powder, bentonite, and clay-on the performance of fire-clay refractory bricks. The results showed that as the percentage of ceramic powder, clay, or bentonite increased up to 1.5%, shrinkage of the bricks decreased and density of the bricks increased while porosity and water absorption decreased and compressive strength increased

The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism

Although multiple reports show that defective genetic networks underlie the aetiology of autism, few have translated into pharmacotherapeutic opportunities. Since drugs compete with endogenous small molecules for protein binding, many successful drugs target large gene families with multiple drug binding sites. Here we search for defective gene family interaction networks (GFINs) in 6,742 patients with the ASDs relative to 12,544 neurologically normal controls, to find potentially druggable genetic targets. We find significant enrichment of structural defects (P≤2.40E-09, 1.8-fold enrichment) in the metabotropic glutamate receptor (GRM) GFIN, previously observed to impact attention deficit hyperactivity disorder (ADHD) and schizophrenia. Also, the MXD-MYC-MAX network of genes, previously implicated in cancer, is significantly enriched (P≤3.83E-23, 2.5-fold enrichment), as is the calmodulin 1 (CALM1) gene interaction network (P≤4.16E-04, 14.4-fold enrichment), which regulates voltage-independent calcium-activated action potentials at the neuronal synapse. We find that multiple defective gene family interactions underlie autism, presenting new translational opportunities to explore for therapeutic interventions

Biomarkers of Multiple Sclerosis

The search for an ideal multiple sclerosis biomarker with good diagnostic value, prognostic reference and an impact on clinical outcome has yet to be realized and is still ongoing. The aim of this review is to establish an overview of the frequent biomarkers for multiple sclerosis that exist to date. The review summarizes the results obtained from electronic databases, as well as thorough manual searches. In this review the sources and methods of biomarkers extraction are described; in addition to the description of each biomarker, determination of the prognostic, diagnostic, disease monitoring and treatment response values besides clinical impact they might possess. We divided the biomarkers into three categories according to the achievement method: laboratory markers, genetic-immunogenetic markers and imaging markers. We have found two biomarkers at the time being considered the gold standard for MS diagnostics. Unfortunately, there does not exist a single solitary marker being able to present reliable diagnostic value, prognostic value, high sensitivity and specificity as well as clinical impact. We need more studies to find the best biomarker for MS.publishersversionPeer reviewe

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362